Axial: https://linktr.ee/axialxyz
Axial partners with great founders and inventors. We invest in early-stage life sciences companies such as Appia Bio, Seranova Bio, Delix Therapeutics, Simcha Therapeutics, among others often when they are no more than an idea. We are fanatical about helping the rare inventor who is compelled to build their own enduring business. If you or someone you know has a great idea or company in life sciences, Axial would be excited to get to know you and possibly invest in your vision and company . We are excited to be in business with you - email us at info@axialvc.com
Evotec is a drug development partnering company, built mainly through trial-and-error. Evotec was founded in 1993 in Germany by Nobel Laureate Manfred Eigen (measuring chemical reactions), Charles Weissmann (cloning interferon) and a set of German entrepreneurs.
Since its founding, the company has had a circuitous route to its current model. Starting with services in 1996. Launching EVOscreen in 2000 working with Rocke, Merck, Eli Lilly. Evotec was a tools company, a drug development company, and a services company.
Evotec generates over $600M in annual revenue and is profitable. Over the last decade or so, Evotec built out its capabilities to run drug development programs and forge partnerships. Evotec has been validating a model where integrated services supports internal drug development.
This approach has allowed Evotec to generate cash to reinvest in its technology in order to increasingly get access to unique economics. Learn more about Evotec and its history here: https://www.evotec.com/en/about/history